AINewsnow

Does treating LLM code reviews like a clinical drug trial improve quality?

I found that once a project codebase gets complex, green tests are insufficient. Asking the LLM to review its own work was always "I got this". So I tried the double-blind clinical protocol and christened it an unpronounacble DBASFR (Double-Blind Adversarial Split-Focus Review), you know, just like…

Read the full story at r/ArtificialInteligence ↗

Timeline · 1 report

  1. 2026-10-20 14:30 · r/ArtificialInteligence
    Does treating LLM code reviews like a clinical drug trial improve quality?

More stories

  1. OpenAI acquires Orchestra Bio — OpenAI News
  2. DeepSeek V4.1 Flash 1017 [GGUF + Abliterated] — r/LocalLLaMA
  3. CoreWeave Completes Acquisition of Weights & Biases — CoreWeave Blog
  4. Build a semantic layer for agentic AI on AWS with AtScale and Amazon Bedrock AgentCore — AWS Machine Learning Blog
  5. Structured outputs for Anthropic Claude models on Amazon Bedrock — AWS Machine Learning Blog
  6. DHS Orders DeepSeek Technology Removed From Federal Civilian IT Systems — Wall Street Journal Technology
  7. Ex-OpenAI worker accused of bugging offices planned to 'flee' to Saudi Arabia, prosecutors say — Sky News Technology
  8. FairStress: A deeper evaluation of fairness in LLM decision-making — Allen Institute for AI (Ai2)

Get the daily brief of stories like this at 6:30 every morning →